biocon: Biocon acquires Eywa Pharma's US-based plant for $7.7 million
Biocon Limited announced that its wholly-owned subsidiary, Biocon Generics Inc., has acquired Eywa Pharma Inc.s oral solid dosage manufacturing facility, located in Cranbury, New Jersey, U.S., effective from September 1, 2023.
Source: indiatimes.com